Oral Melatonin Doesn't Help Appetite in Patients with Advanced Cancer

This article originally appeared here.
Share this content:
Oral Melatonin Has No Effect on Appetite in Advanced Cancer
Oral Melatonin Has No Effect on Appetite in Advanced Cancer

(HealthDay News) -- Oral melatonin does not improve appetite, weight, or quality of life for patients with cachexia due to advanced cancer, according to research published online Feb. 25 in the Journal of Clinical Oncology.

In an effort to determine whether melatonin may be associated with appetite improvement in patients with cancer cachexia, Egidio Del Fabbro, M.D., of the University of Texas MD Anderson Cancer Center in Houston, and colleagues performed a randomized, double-blind, 28-day trial of melatonin 20 mg versus placebo in 48 patients with advanced lung or gastrointestinal cancer.

This study was closed for futility after the interim analysis was performed and results suggested that, even with a larger sample size, the results were not likely to change. No significant difference was observed between melatonin- and placebo-treated groups with regard to appetite, other symptoms, weight, score on the Functional Assessment of Anorexia/Cachexia Therapy questionnaire, toxicity, or survival.

"In cachectic patients with advanced lung or gastrointestinal cancer, oral melatonin 20 mg at night did not improve appetite, weight, or quality of life compared with placebo," the authors write. "More research is required to determine whether melatonin has a role in the supportive care of patients earlier in their disease trajectory."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs